Literature DB >> 17709373

Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor.

Beatriz E Rendon1, Thierry Roger, Ivo Teneng, Ming Zhao, Yousef Al-Abed, Thierry Calandra, Robert A Mitchell.   

Abstract

Macrophage migration inhibitory factor (MIF) is expressed and secreted in response to mitogens and integrin-dependent cell adhesion. Once released, autocrine MIF promotes the activation of RhoA GTPase leading to cell cycle progression in rodent fibroblasts. We now report that small interfering RNA-mediated knockdown of MIF and MIF small molecule antagonism results in a greater than 90% loss of both the migratory and invasive potential of human lung adenocarcinoma cells. Correlating with these phenotypes is a substantial reduction in steady state as well as serum-induced effector binding activity of the Rho GTPase family member, Rac1, in MIF-deficient cells. Conversely, MIF overexpression by adenovirus in human lung adenocarcinoma cells induces a dramatic enhancement of cell migration, and co-expression of a dominant interfering mutant of Rac1 (Rac1(N17)) completely abrogates this effect. Finally, our results indicate that MIF depletion results in defective partitioning of Rac1 to caveolin-containing membrane microdomains, raising the possibility that MIF promotes Rac1 activity and subsequent tumor cell motility through lipid raft stabilization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709373     DOI: 10.1074/jbc.M704898200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

2.  Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts.

Authors:  Maciej Tarnowski; Katarzyna Grymula; Rui Liu; Joanna Tarnowska; Justyna Drukala; Janina Ratajczak; Robert A Mitchell; Mariusz Z Ratajczak; Magda Kucia
Journal:  Mol Cancer Res       Date:  2010-09-22       Impact factor: 5.852

3.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

4.  Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.

Authors:  Xiao-Bing Wang; Xiao-Ying Tian; Yang Li; Bin Li; Zhi Li
Journal:  J Neurooncol       Date:  2011-07-03       Impact factor: 4.130

5.  Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.

Authors:  Leona Mawhinney; Michelle E Armstrong; Ciaran O' Reilly; Richard Bucala; Lin Leng; Gunter Fingerle-Rowson; Darren Fayne; Michael P Keane; Aisling Tynan; Lewena Maher; Gordon Cooke; David Lloyd; Helen Conroy; Seamas C Donnelly
Journal:  Mol Med       Date:  2015-04-16       Impact factor: 6.354

6.  Lung cancer diagnosis from proteomic analysis of preinvasive lesions.

Authors:  S M Jamshedur Rahman; Adriana L Gonzalez; Ming Li; Erin H Seeley; Lisa J Zimmerman; Xueqiong J Zhang; M Lisa Manier; Sandra J Olson; Ronak N Shah; Alison N Miller; Joe B Putnam; York E Miller; Wilbur A Franklin; William J Blot; David P Carbone; Yu Shyr; Richard M Caprioli; Pierre P Massion
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

7.  Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.

Authors:  Nadège Kindt; Fabrice Journe; Guy Laurent; Sven Saussez
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

8.  Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.

Authors:  Hui Liu; Gang Chen; Wei Zhang; Jun-Yi Zhu; Zhao-Quan Lin; Zhong-Cheng Gong; Feng-Qin Wang; Jun Jia; Zhi-Jun Sun; Yi-Fang Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-12       Impact factor: 4.553

Review 9.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

10.  Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.

Authors:  Xihui Xu; Yinan Hua; Sreejayan Nair; Richard Bucala; Jun Ren
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.